Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | TRPV4 | Q9HBA0 | 6/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23842657 | 0.88 | SLC6A2 (0.49) | PGRTRPV4SLC6A2SLC6A4SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL23830800 | 0.84 | SLC6A2 (0.45) | SLC6A2SLC6A4SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL28932726 | 0.83 | TRPV4 (0.37) | TRPV4 | |
| Trifluoroacetic Acid SCHEMBL23830498 | 0.81 | EPHX2 (0.46) | — | |
| Trifluoroacetic Acid SCHEMBL23850944 | 0.81 | PDE9A (0.44) | SLC6A2SLC6A4SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL23830454 | 0.79 | SLC6A4 (0.51) | SLC6A2SLC6A4SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL23850725 | 0.78 | SLC6A2 (0.48) | SLC6A2SLC6A4SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL23830859 | 0.77 | SLC6A2 (0.45) | SLC6A2SLC6A4SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL23830576 | 0.77 | MGLL (0.40) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL24298603 | 0.76 | ACSL1 (0.46) | PGRTRPV4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210292305-A1 | Cyclic Ureas | SIRONAX LTD (KY) | 2021-09-23 | — | — | US | disclosed |
| CN-113302183-A | Cyclic ureas | 圣瑞诺有限公司 | 2021-08-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210292305-A1 | Cyclic Ureas | RIPK1, RIPK3, RIPK4 | PGR 3065/4885TRPV4 2451/4885SLC6A2 4844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.